Research progress of new oral anticoagulants in nonvalvular atrial fibrillation
10.3969/j.issn.1008-0074.2018.03.33
- VernacularTitle:新型抗凝口服药在非瓣膜性房颤中的研究进展
- Author:
Wen-Hao CHEN
1
;
Huan-Ji ZHANG
;
You-Sheng GUO
;
Dong-Hui ZHANG
Author Information
1. 广东医科大学研究生院
- Keywords:
Atrial fibrillation;
Coronary artery disease;
Anticoagulants
- From:
Chinese Journal of cardiovascular Rehabilitation Medicine
2018;27(3):364-367
- CountryChina
- Language:Chinese
-
Abstract:
Oral anticoagulants has become the cornerstone preventing thromboembolic complications in patients with atrial fibrillation (AF ) who are at high risk for stroke .Advantages of new oral anticoagulants (NOAC ) include greater pharmacokinetic predictability ,less risk of fatal or intracranial hemorrhage compared to vitamin K antago-nists ,fewer drug-food interactions and no long time monitoring of international standardized ratios etc .The present article focused on recent studies of NOAC in AF complicated coronary diseases ,for secondary prevention of stroke and its specific antagonists .
